scispace - formally typeset
Journal ArticleDOI

A comparison between des‐γ‐carboxy prothrombin and α‐fetoprotein as markers of hepatocellular carcinoma in southern African Blacks

Reads0
Chats0
TLDR
DCP is less useful than α‐FP as a single marker of hepatocellular carcinoma in southern African Blacks, however, the two markers can be used together profitably.
Abstract
Abstrat Des-γ-carboxy prothrombin (DCP), a precursor of prothrombin, has been reported recently to be as good a marker, or even better, of hepatocellular carcinoma than α-fetoprotein (α-FP). The sensitivity, specificity and predictive values of the two markers have been compared in 98 southern African Blacks with hepatocellular carcinoma and in 120 Black controls with various diseases which might be mistaken clinically for this tumour: 32 with hepatic metastases, 33 with amoebic hepatic abscesses, and 55 with chronic hepatic parenchymal disease. DCP levels were measured using a chromogenic assay with Dispholidus typus venom and staphylocoagulase. The agreement between the two methods was excellent (r= 0.995). α-FP concentrations were measured by radioimmunoassay. DCP levels were raised in 66 of 98 patients (67.3%) and α-FP levels in 82 of 98 patients (83.7%) with hepatocellular carcinoma (P= 0.006). The specificity of DCP was also less than that of α-FP, although the difference just failed to reach statistical significance (P= 0.085). The predictive values of both a positive and a negative test for DCP were significantly less than those for α-FP (P= 0.047 and 0.048, respectively). When, in an attempt to eliminate false positive results, the diagnostic cut-off level for DCP was increased from 1.5 to 5.0 mu/ml and that of α-FP from 20 to 400 ng/ml, the differences between the two markers remained the same. If the two tests were used together, the number of false negative α-FP results was reduced from 16.3% to 7.1% and the number of equivocal α-FP results was reduced from 11.2% to 5.1%. It is concluded that DCP is less useful than α-FP as a single marker of hepatocellular carcinoma in southern African Blacks. However, the two markers can be used together profitably.

read more

Citations
More filters
Journal ArticleDOI

Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review

TL;DR: Investigation of diagnostic accuracy of AFP in small HCC was substantially limited and surveillance including other tumor markers with optimal cutoff value should be conducted to confirm the efficacy of the policy.
Journal ArticleDOI

The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis

TL;DR: AFP levels in serum showed good accuracy in HCC diagnosis, and the threshold of AFP with 400 ng/mL was better than that of 200 ng/ mL in terms of sensitivity and specificity no matter AFP is used alone or combined with ultrasound.
Journal ArticleDOI

Plasma des-γ-carboxyprothrombin in the early stage of hepatocellular carcinoma

TL;DR: It is concluded that des‐γ‐carboxyprothrombin assay may serve as a complementary tool in the diagnosis and follow‐up of hepatocellular carcinoma and is particularly useful in patients with normal or low α‐fetoprotein levels.
Journal ArticleDOI

Serum levels of des-γ-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma

TL;DR: The sensitivity of this revised EIA kit has increased while high specificity to HCC has been maintained, and the serum levels of DCP measured by this revised kit in relation to the clinicopathologic features of solitary HCC were examined.
Journal ArticleDOI

Measurement of serum levels of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity

TL;DR: In this revised DCP kit, the blank value has been reduced, making it now possible to obtain a normal value, and its usefulness as a tumor marker for HCC was evaluated.
References
More filters
Journal ArticleDOI

Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma.

TL;DR: Levels of the abnormal prothrombin were low in patients with chronic active hepatitis or metastatic carcinoma involving the liver, and undetectable in normal subjects, while Serum α-fetoprotein levels correlated poorly with abnormal-prothrom bin levels.
Journal ArticleDOI

Production of abnormal prothrombin (des-gamma-carboxy prothrombin) by hepatocellular carcinoma. A clinical and experimental study.

TL;DR: Increased plasma DCP appears useful for the diagnosis of hepatocellular carcinoma, and the mechanism for the increase is elucidated, which is dependent on the amount of vitamin K available in the medium.
Journal ArticleDOI

Alpha-fetoprotein in primary liver cancer and other diseases.

M Kew
- 01 Oct 1974 - 
TL;DR: With the introduction of more sensitive methods for its detection, raised levels of the globulin have been shown in a variety of other liver diseases, so that its specificity for primary hepatocellular cancer is far from absolute.
Journal ArticleDOI

A New Method to Assay Des-γ-carboxyprothrombin

TL;DR: The DCP assay appears more sensitive and more specific than the a-fetoprotein assay for the diagnosis of hepatocellular carcinoma; furthermore, both tests are complementary.
Journal ArticleDOI

Abnormal prothrombin in the plasma of rats carrying hepatic tumors

TL;DR: The data suggest that the secretion of abnormal prothrombin by hepatocellular tumors is the result of normal expression of the prothROMbin gene by those tumors and a failure of the tumor to express the carboxylase gene.
Related Papers (5)